1 / 28

Nizhny Novgorod-Maryland Biotechnology Partnership

Nizhny Novgorod-Maryland Biotechnology Partnership. September 10-11, 2013. Maryland-Russia Collaborations. MARYLAND. 95. CONNECTED GLOBALLY and REGIONALLY. 600 mi. 500 mi. 400 mi. 300 mi. UNSURPASSED BUSINESS ACCESS:. 200 mi. 100 mi. Air: BWI, Washington-Dulles & Reagan International.

maili
Download Presentation

Nizhny Novgorod-Maryland Biotechnology Partnership

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Nizhny Novgorod-MarylandBiotechnology Partnership September 10-11, 2013

  2. Maryland-Russia Collaborations

  3. MARYLAND 95 CONNECTED GLOBALLY and REGIONALLY 600 mi. 500 mi. 400 mi. 300 mi. UNSURPASSED BUSINESS ACCESS: 200 mi. 100 mi. • Air: BWI, Washington-Dulles & Reagan International • Rail: AmTrak corridor • Road: Multi interstate Same day or overnight access to 1/3 of U.S. industry, markets, and population • Baltimore’s deepwater port Just two hour access to 80% of the U.S. pharmaceutical industry and more than 2,000 biotechnology companies

  4. The Government as a Catalyst of Innovation and Growth: the Case for BioMaryland 2020 Judy Britz, Ph.D., Executive Director BioMaryland Center From Research to Reality to Revenues

  5. Governor O’Malley committed to $1.3 Billion Investment/10 Years BioMaryland 2020

  6. Maryland Biotechnology Industry Genomics Proteomics Therapeutics Bioinformatics BioDefense Diagnostics Biomanufacturing Agriculture/Food Environment Devices

  7. Dmitri Mendeleev • Chemist • Periodic Chart • 1st Vodka Standards • Founded 1st Oil Refinery

  8. Increase access to capital • Connect entrepreneurs with resources • Grow jobs in the BIO industry • Assist translation of research to products • Other • Provide Business Plan Feedback • Identify Partners, Collaborators and Clients • Match Training and Workforce

  9. > 500 BioCompanies • Focus: 50% Biotherapeutics • 25% Medical Devices/Diagnostics • 25% CROs/Research Tools • > 34,000 Employees • - Average Salary: $91,100 • > $10 Billion in Revenues

  10. UMD- ACES ECBC USAMRIID USAMRMC NIBC, NBACC, NCI JHU UMBC MD DBED JHU APL FDA UMB-SOM, IHV UMD NIST JCVI • UMCES FDA CVM USUHS WRAIR FDA CFSAN BARC USDA UMCP VMRCVM MDA NIH GTU GWU

  11. Maryland’s Unique Assets • National Institutes of Health (NIH) • Food and Drug Administration (FDA) • Center for Medicare and Medicaid Services (CMS) • Center for Excellence in Regulatory Science (CERSI) • Food Safety and Inspection Service (FSIS) • Federal Labs: BioDefense and Human Health • Johns Hopkins University • University of Maryland System

  12. Maryland Center for Excellence in Regulatory Science and Innovation

  13. $1.1 B Acquisition

  14. MD STEM Cell Research Fund MD Innovation Initiative (MII) Phase II Phase I Phase III Tech. Commercialization Fund Technology Validation Program Patent Assistance Program Angel Affinity Funds Maryland Industrial Partnerships (MIPS) Translational Research Award Biotechnology Commercialization Award KEY: Biotechnology Tax Credit TEDCO Cybersecurity Tax Credit USM MBC Research and Development Tax Credit DBED MD Venture Fund Universities Companies Basic Research Translational Research Product Development

  15. Cumulative Investment • BioMaryland Award Programs: $7M • Maryland Innovation Initiative: 10.8M • Biotechnology Tax Credits: $48M • InvestMaryland: $84M next 3yrs • Stem Cell Funding: ~$100M • R&D Tax Credit: >$30M

  16. BioMaryland Center’s Biotechnology Development Awards Program • Applicants have tripled from since inception • Two main Categories: Translational Research and Commercialization Awards • >$7.0M Awarded to >30 Companies and 3 University projects

  17. Maryland Innovation Initiative • Purpose: Commercialization of University Research/IP • Participating: Hopkins, University of Maryland (UMBC, UMB, UMCP),Morgan State • 2012: $5.8M First Year Funding • 2013: $5M Followon • Companies who have licensed University Research eligible • Administered by TEDCO

  18. BioMaryland LIFE Prize • Collaborative Prize with Johns Hopkins and University of Maryland • Annual Alliance Meeting • 100+ Angels, VCs, Pharma, Entrepreneurs • Two $50,000 Competitive Awards • Abell Foundation added $100,000 to pool

  19. DBED’s Biotechnology Investor Tax Credit • Model Program for Nation for Angel Investors • 2013: Increase from $8M to $10M • $48M in credits deployed to >60 companies • >$90 leveraged in investment • Goal: $24M by 2020

  20. DBED’s Invest Maryland VC Program • 2011- InvestMaryland Legislation passed • 2012 - $84 M Raised in Tax Credit Auction • $28M+ Maryland Venture Fund • $56M Private Venture Capital • First Bioinvestments • BrainscopeAdLyfe • TheranosticsPlasmonix • PathSensors

  21. InvestMaryland Challenge • Statewide Business Plan Competition • $425K in Prizes • Over 200 Applications received • Life Science – Maryland Only (55 Companies) • Cyber/IT – Maryland Only • General – Outside Maryland

  22. Other Sources of Capital • Leveraged financing from the private sector • Direct financing (Loans, Contract Financing) • Loan Guarantees & Credit Enhancement • Tax Exempt and Taxable-Revenue Bonds • Tax Credits (Job Creation, Enterprise Zone) • Export Assistance • Other State Resources: TEDCO, MIPs (University) • Federal Sources: SBIR/STTR

  23. FREE Access to Market Research Resources BioMed Tracker • Frost & Sullivan • Deloitte Recap • MedTrack

  24. San Diego June 23-26, 2014

  25. www.Bio.Maryland.gov

  26. Finland Ukraine Netherlands Sweden Norway Poland Iceland Czech Republic Germany Belgium Russia Ireland Canada Bulgaria United Kingdom Kazakhstan Mongolia France Switzerland Turkey Japan Spain United States Bermuda China Israel Iran Iraq Pakistan Portugal Italy Algeria Libya South Korea Morocco The Bahamas Cuba Saudi Arabia Egypt Taiwan Dominican Republic India Hong King Puerto Rico U.S. Virgin Islands Vietnam Jamaica Mexico Barbados Sudan Guatemala Thailand Guam U.A.E. Philippines Venezuela British Virgin Islands Costa Rica Ethiopia Sri Lanka Côte d'Ivoire Panama Ghana Yemen Columbia Malaysia Nigeria Uganda Ecuador Papua New Guinea Maldives Cameroon Kenya Indonesia Brazil Tanzania Peru Singapore Angola Bolivia Namibia Mauritius Somalia Australia Uruguay Chile South Africa Argentina New Zealand

  27. From Research to Reality to Revenues Спасибо !

More Related